Spring Intern, gRED Operations — Systems & Process Excellence

Roche; South San Francisco (CA); On-site; USD 62,000 - 72,000; Full time

Benefits offered by this job

Stipend provided

Paid holidays

Challenging projects

Job summary

Genentech in South San Francisco is offering a 6‑month intensive, full‑time Spring Intern role in gRED Business Operations (Systems & Process). You will support process and system change initiatives, map business processes, and contribute to AI‑assisted automation projects under senior guidance.

The program starts January 2027 with a stipend based on location, paid holidays, and ownership of challenging, impactful projects within biotechnology.

Qualifications

• Pursuing or holding an associate, bachelor, or master’s degree.
• Majors include Industrial Engineering, Business Administration, Biology, Biotechnology, E-Mechanical Eng, Data Science, CS, Economics.
• Interest in automation and AI/agentic tools applied to operations.
• Good communication and collaboration skills.

Responsibilities

• Support process and system change initiatives with guidance from senior team members.
• Provide project management support for systems and process improvement projects.
• Recommend process improvements and assess their effectiveness.
• Map and analyze business processes to support system improvements.
• Lead and support development of value-added process improvements and AI automation solutions.

Skills

Health life sciences

Laboratory experience

Project management

Automation AI tools

Education

Associate’s Degree

Bachelor’s Degree

Master’s Degree

Tools

Vibe coding

App Script

Claude Code

Codex

Job description

Genentech in South San Francisco is offering a 6‑month intensive, full‑time Spring Intern role in gRED Business Operations (Systems & Process). You will support process and system change initiatives, map business processes, and contribute to AI‑assisted automation projects under senior guidance.

The program starts January 2027 with a stipend based on location, paid holidays, and ownership of challenging, impactful projects within biotechnology.